Earnings calendar

Royalty Pharma plc (RPRX) earnings: date, estimates, results and stock reactions

Next earnings: Q4 FY2026 on 2027-02-10 (expected, time not announced). EPS estimate 1.53, revenue estimate 960.7M.

Over the last 12 reports the stock moved 2.3% on average (either way), rising 7 times and falling 5. EPS beat estimates 10 of 12 times; revenue 4 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-11-041.211.18+2.5%890.0M884.8M+1.8%
Q2 FY20262026-08-051.321.27+3.9%773.0M758.9M-0.4%
Q1 FY20262026-05-061.301.21+7.4%925.0M881.7M-0.5%
Q4 FY20252026-02-111.461.29+13.2%874.0M807.0M+1.3%
Q3 FY20252025-11-051.170.99+17.7%609.3M717.4M+7.8%
Q2 FY20252025-08-061.141.03+10.7%578.7M673.0M-2.4%
Q1 FY20252025-05-081.060.95+11.2%568.2M705.3M+1.2%
Q4 FY20242025-02-111.150.99+16.2%594.0M687.1M+2.0%

RPRX stock report · Earnings calendar